NEW YORK (GenomeWeb News) — Illumina has licensed Oxford Gene Technology patents that will enable Illumina to detect DNA sequence variations, OGT said today.
 
Under the deal, OGT has granted Illumina access to the property through the life of the patents and provides “certain rights with respect to SNP genotyping,” OGT said.
 
Illumina CEO Jay Flatley said the licensing agreement is “relevant to a portion of our products and will not materially impact our expected financial results."
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.

Jun
12
Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.

Jun
28
Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.